SGLT2i treatment during AKI and its association with major adverse kidney events.

Autor: Alcantar-Vallin L; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Zaragoza JJ; Intensive Care Unit, Hospital H+ Queretaro, Queretaro, Mexico., Díaz-Villavicencio B; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Hernandez-Morales K; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Camacho-Guerrero JR; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Perez-Venegas MA; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Carmona-Morales EJ; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Oseguera-Gonzalez AN; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Murguia-Soto C; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Chávez-Alonso G; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Arredondo-Dubois JM; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Orozco-Chan CE; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Gómez-Fregoso JA; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico., Rodríguez-García FG; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico., Navarro-Blackaller G; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Medina-González R; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico., Martínez Gallardo-González A; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Abundis-Mora GJ; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico., Vega-Vega O; Departamento Nefrología y Metabolismo Mineral, Instituto Nacional de Ciencia Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., García-García G; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico., Chávez-Iñiguez JS; Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.; University of Guadalajara Health Sciences Center, Guadalajara, Jalisco, Mexico.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2024 Jun 12; Vol. 15, pp. 1356991. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).